Mobile

A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole, in patients with C.difficile-associated diarrhea

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004676-37

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the safety and tolerability of GT267-004 versus vancomycin, and GT267-004 versus metronidazole, in patients with Clostridium difficile-associated diarrhea (CDAD). To compare the effect of GT267-004 versus vancomycin, and GT276-004 versus metronidazole, on the resolution of CDAD. To compare the effect of GT267-004 versus vancomycin, and GT276-004 versus metronidazole, on the rate of CDAD recurrence during the follow-up period. To compare the safety, tolerability and efficacy of vancomycin versus metronidazole for resolution of CDAD and recurrence rates.

Critère d'inclusion

  • C. difficile-associated diarrhea (CDAD)

Liens